FOXM1 and cancer: Despite the unexpected findings of invasion assay, we assessed by RT-qPCR that some FOXM1 downstream targets involved in metastasis, cancer progression, and cisplatin resistance, such as MMP2 [19] and MACC1 [48–50], were specifically down-regulated in OSPC2 cells after FOXM1 silencing.